Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia (NCT06229860)
Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia
🩺 Plain-English Summary (8th-Grade Level)
This is an observational pilot study to examine the association between a patient's personality and adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.
Who can join: Review the eligibility criteria below.
Location: Chao Family Comprehensive Cancer Center University of California, Irvine — Orange, California
Age range: 18 Years
🧪 Interventions in This Study
- Interview (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Chao Family Comprehensive Cancer Center University of California, Irvine — Orange, California
📞 Contact the Study Coordinator
Phone: (877) 827-8839
Email: ucstudy@uci.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Myeloid Leukemia
- Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population — Houston, Texas
- Selumetinib and Azacitidine in High Risk Chronic Blood Cancers — Chicago, Illinois
- A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia — New York, New York
- Study of Olverembatinib (HQP1351) in Patients With CP-CML — Houston, Texas
- Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase — Houston, Texas
- Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. — Houston, Texas
Explore by condition: All Chronic Myeloid Leukemia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.